Threonine

Threonine

SCHEMBL6033503

CC(O)C(N)C(=O)O.NC(CCO)C(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
SLC1A3 P43003 3/20 0.43
SLC1A2 P43004 3/20 0.43
SLC1A1 P43005 3/20 0.43
SLC7A5 Q01650 2/20 0.43
GSR P00390 2/20 0.43
GRM8 O00222 1/20 0.43
GRM6 O15303 1/20 0.43
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
CYP1A2 P05177 1/20 0.43
GRIK1 P39086 1/20 0.43
GRM5 P41594 1/20 0.43
GRIA1 P42261 1/20 0.43
GRIA2 P42262 1/20 0.43
GRIA3 P42263 1/20 0.43
GRIA4 P48058 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIK2 Q13002 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Threonine SCHEMBL12482108 1.00 ALDH1A1 (0.44) ALDH1A1SLC1A3SLC1A2SLC1A1SLC7A5
Threonine SCHEMBL6033506 1.00 ALDH1A1 (0.44) ALDH1A1SLC1A3SLC1A2SLC1A1SLC7A5
Threonine SCHEMBL382179 0.93 GLUL (0.42) GRM8GRM6GRM7GRM4
Threonine SCHEMBL6937624 0.93 GLUL (0.42) GRM8GRM6GRM7GRM4
Valine SCHEMBL14485817 0.86 SLC7A5 (0.62) ALDH1A1SLC1A3SLC1A2SLC1A1SLC7A5
Valine SCHEMBL14485812 0.86 SLC7A5 (0.62) ALDH1A1SLC1A3SLC1A2SLC1A1SLC7A5
Threonine SCHEMBL9716088 0.84 USP2 (0.44) ALDH1A1SLC1A3SLC1A2SLC1A1SLC7A5
Threonine SCHEMBL1067389 0.84 USP2 (0.44) ALDH1A1SLC1A3SLC1A2SLC1A1SLC7A5
Threonine SCHEMBL1067383 0.84 USP2 (0.44) ALDH1A1SLC1A3SLC1A2SLC1A1SLC7A5
Threonine SCHEMBL1697282 0.84 USP2 (0.44) ALDH1A1SLC1A3SLC1A2SLC1A1SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104561163-A Process for producing L-amino acid CJ CHEILJEDANG CORP 2015-04-29 CN disclosed
CN-100434440-C Antibodies directed to tumor necrosis factor and uses thereof ABGENIX INC (US) 2008-11-19 CN disclosed
CN-1878795-A Antibodies directed to phospholipase A2 and uses thereof ABGENIX INC (US) 2006-12-13 CN disclosed
EP-1660017-A2 AMINO ACID PRODRUGS Signature R&D Holdings, LLC (US) 2006-05-31 EP disclosed
CN-1745101-A Antibodies against tumor necrosis factor and uses thereof ABGENIX INC (US) 2006-03-08 CN disclosed
WO-2005046575-A2 AMINO ACID PRODRUGS SIGNATURE R & D HOLDINGS, LCC (US) 2005-05-26 WO disclosed
CN-1108955-A The use of compositions for combating tumour diseases CIBA GEIGY AG (CH) 1995-09-27 CN disclosed
EP-0338790-A2 Production of homoserine and its derivatives such as threonine derivatives and methionine precursors BIOTECHNICA INTERNATIONAL, INC. (US) 1989-10-25 EP disclosed